NEWS

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
NEWS
05:02PM Where Did 6 Million Missing Workers Go?
04:44PM Tenet Raises $4.6 Billion in Two-Part Debt Sale to Fund Buyout
04:44PM Health Management Seen Succumbing to Lone Bid: Real M&A
04:38PM Lehman Sign Is on the Block Again
04:32PM Awful Spending Is the New Black
04:28PM OGX Seeks Lifeline From Creditors
04:19PM Dow Posts Second-Best Week of 2013; Fed Watch Ahead
04:17PM Roth Resigns from J.C. Penney Board
04:10PM Who'll be getting rich off Twitter
04:03PM Corn Extends Decline to Near 4-Week Low on USDA Forecast
04:00PM NewsWatch: U.S. stocks knock out second week of gains
03:57PM India Panel Slashes Growth Forecast
03:46PM Top Ten: An unexceptional week for Apple and America
03:29PM Chuck Jaffe: Funds erase financial crisis from history
03:29PM Jennifer Waters's Consumer Confidential: Book your holiday travel now
03:28PM Energy Stocks: Energy stocks gain 1.3% on week
03:22PM WTI Crude Caps Biggest Weekly Drop Since July on Syria
03:22PM Will Twitter avoid Facebook's IPO flubs?
03:21PM Tech Stocks: Twitter IPO buzz puts social-media stocks in focus
03:15PM Market Snapshot: U.S. stocks knock out second week of gains
03:07PM United Airlines Says it Will Honor Mistake Fares
03:00PM Chile’s Peso Falls Most in Emerging Markets After Central Bank
03:00PM Freeport’s CFO Freeport’s CFO Says Limited Partnership O
02:54PM Canada Stocks Rise as Easing Fed Concern Boosts Commodity Shares
02:48PM Mezcal worms its way into liquor cabinets
02:30PM Movers & Shakers: Apple retreats in wake of price target cut
02:27PM Tropical Systems Flank Southern Mexico Bringing Flash Floods
02:26PM Futures Movers: Oil logs 2.1% weekly loss, but holds above $108
02:25PM U.S. Dollar Faces New Competition as Safe Haven Currency
02:16PM Is Kinder Morgan a Trap or a Treasure?
02:14PM OGX May Tap Creditors for More Cash to Avert Bankruptcy
02:10PM What Twitter is worth today
02:00PM Bloomberg Says He Won’t Endorse in New York Mayoral Race
02:00PM U.S. Stocks Rise as Disappointing Data Ease Taper Concern
01:57PM 3 Ways to Value Twitter’s IPO: From $20 Billion to Bust
01:52PM China's Improving Economy: Out of the Woods or Still a Giant Bubble?
01:39PM Record Chocolate Sales Boosting Cocoa Demand to Leave Shortages
01:32PM Codere Seen Triggering Swaps on Coupon Miss: Corporate Finance
01:14PM Bits Blog: Twitter vs. Facebook: A Tale of Two Sites
01:12PM Fidelity Sees Bank of Canada Raising Rates After Bernanke
01:03PM Housing Markets About to Get Squeezed
12:59PM Glencore Agrees to Study $3 Billion Congo Iron Ore Mine
12:59PM Canada Stocks Rebound as Commodity Shares Rally Amid Syria Talks
12:54PM Tropical Systems Flank Southern Mexico Bringing Deadly Flooding
12:42PM Treasuries Gain Amid Weaker-Than-Forecast Data
12:30PM Russia Holds Rates as Nabiullina Moves to Target CPI
12:30PM Dollar Heads for Weekly Drop Before Fed Considers Stimulus Taper
12:22PM Aquino Raises Using Force Against Rebels in Southern Philippines
12:16PM U.K. Stocks Little Changed After U.S. Retail Sales Report
12:05PM Oil Falls on Syria Talks, Gold Drops; S&P 500 Advance
12:05PM Top 1% Getting 95% of Income Gains: Is Washington Responsible?
12:00PM By every measure, the big banks are bigger
11:50AM Funds that already own Twitter fly on IPO news
11:49AM China Hems in Private Sleuths Seeking Fraud
11:38AM Hogs Gain as Overseas Demand Climbs for U.S. Pork; Cattle Gain
11:23AM U.S. Stocks Rise as Investors Weigh Economic Reports
11:13AM Google Jet Fleet Loses a Pentagon Fuel Perk
11:10AM Canadian Dollar Falls 2nd Day on Record Household-Debt Growth
11:03AM Europe Stocks Post Best Week Since April on Economic Data
10:56AM Natural Gas Climbs on Speculation Heat Will Slow Inventory Gains
10:56AM Crude Poised for Biggest Weekly Drop Since July on Syria
10:43AM Natural Gas Gains on Outlook Heat Slowing Supply Gain
10:36AM Off the Charts: Investors in Europe See a Glass Half Full and Rising
10:28AM Mall Owner Stocks Go From First to Last as Spending Slows
10:28AM Oil Falls on Syria Talks, Gold Drops; S&P 500 Fluctuates
10:28AM U.S. Stocks Fluctuate Amid Retail Sales, Confidence Data
10:22AM Brazil Real Heads for Weekly Advance on Eased Concern Over Fed
10:17AM 5 years after Lehman: Where are key players now?
10:15AM Treasuries Gain as Retail Sales Growth Trails Forecast
10:15AM Occidental Said to Seek Offers for 40% Stake in Middle East Unit
10:07AM Modi Is India Opposition BJP Pick for Prime Minister Before Poll
10:01AM Lhota Would Fund Universal NYC Pre-K Without Higher Taxes
10:01AM Italian 10-Year Bonds Drop as Portugal’s Decline for Fourth Day
09:55AM Crude Heads for Biggest Weekly Drop Since July on Syria
09:44AM The September stock surge continues
09:40AM Dollar Fluctuates After August Retail Sales Forecast
09:40AM U.S. Stocks Rise Amid Retail Sales, Producer Prices Data
09:32AM Fire at Jersey Shore’s Boardwalk Follows Sandy’s Wrath
09:32AM Natural Gas Drops as Milder Weather May Spur Inventory Increase
09:25AM Dollar Falls as Retail Sales Increase Less Than Forecast
09:25AM Solberg Targets Krone in First Major Speech After Election
09:12AM Pound Rises to Seven-Month High After Construction Report
09:05AM Investors Trapped in Expensive Stocks as Fed Nears Exit
08:53AM Markets Close Slightly Higher, Anticipating Fed Action
08:43AM Treasuries Gain as Retail Sales Trail Forecast
08:43AM U.S. Stock Futures Are Little Changed After Retail Sales
08:42AM UAW Confident It Will Organize Tennessee VW Plant
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 15

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 11

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 20

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 17

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 22

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 19

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 20

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 23

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 18

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights into Stella-Jones Conference Call for Q3 Results

Updated Category News Views 70

Upcoming Conference Call for Stella-Jones Inc. Stella-Jones Inc. (TSX: SJ), a prominent player in the manufacturing of pressure-treated wood products, is set to hold a significant conference call to discuss its third quarter results. Details of the Conference Call The conference call is open to investors, analysts, and all interested parties. It will take place on...

Continue Reading
Total Voting Rights Announcement for Northern Venture Trust

Updated Category News Views 75

Update on Total Voting Rights Northern Venture Trust PLC has released a key update concerning its total voting rights. In line with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules, the Company is informing the market about its present capital structure. Overview of Ordinary Shares As per the latest information, Northern Venture Trust PLC's...

Continue Reading
Northrop Grumman Faces Investor Scrutiny Amid Financial Decline

Updated Category News Views 431

Investor Concerns Around Northrop Grumman Investors holding shares in Northrop Grumman Corporation (NYSE: NOC) are facing critical developments as they are encouraged to evaluate their positions in light of recent financial disclosures and ongoing investigations by legal entities. This alert revolves around Northrop Grumman's recent performance and future implications...

Continue Reading
Nature's Sunshine Welcomes Katie May to Board Leadership

Updated Category News Views 420

Nature's Sunshine Embraces New Leadership with Katie A. May Nature's Sunshine Products, Inc. is thrilled to announce that Katie A. May has joined its board of directors, marking a significant step in enhancing leadership and direction within the company. With a rich background in ecommerce and logistics, Katie's new role reflects the company's commitment to further...

Continue Reading
NewAmsterdam Pharma Announces Participation in Key Investor Conferences

Updated Category News Views 79

NewAmsterdam Pharma to Attend Investor Conferences NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS) is a leading biopharmaceutical firm committed to creating innovative oral medications designed to reduce low-density lipoprotein (LDL) cholesterol levels for individuals at risk of cardiovascular disease (CVD). The company is preparing for a series of upcoming investor...

Continue Reading